TARO-CAPECITABINE
We will be changing our web hosting provider during the next few days.
During this time, the site may work slowly or be unavailable.
We apologize for the inconvenience and kindly ask you to be patient!
Identification of Taro-Capecitabine
Please sign up for a free trial to see the description of this product.
Examples of the descriptions of OTHER drugs:
Lipitor 10 mg
Apo-Irbesartan 150 mg
Crestor 20 mg
Google image searchProduct monograph
Active ingredient
capecitabine, 150 MG
DIN: 02457490
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: TARO PHARMACEUTICALS INC
Date: 31-AUG-2017
ATC:
- L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
- L01B — ANTIMETABOLITES (ATC, ATC/DDD)
- L01BC — Pyrimidine analogues (ATC, ATC/DDD)
- L01BC06 — CAPECITABINE (ATC/DDD)
Reference brand drug: Xeloda
Pharmaceutical standard: MFR
External Links for Taro-Capecitabine
Search on Google
- Taro-Capecitabine side effects
- Taro-Capecitabine dosage
- capecitabine side effects
- capecitabine dosage
Taro Pharmaceuticals Inc
Go to Taro website to see drug product details. Sometimes you can find taro-capecitabine photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.
